Citation

Javed Q, Chorghade A, Javed S, Pervez Y. Progress in Neurology and Psychiatry 2014; 18(4): 23-27.

Copyright

(Copyright © 2014)

DOI

10.1002/pnp.340

PMID

unavailable

Abstract

No psychotropic drug is specifically licensed for the management of emotionally unstable borderline personality disorder. Prescribing 'off-label' places additional responsibilities on the prescriber and may increase liability if there are adverse effects. This case report describes a patient with borderline personality disorder who was started on zuclopenthixol decanoate with successful outcome in terms of reducing self-harming behaviour and impulsivity. © 2014 John Wiley and Sons, Ltd.

Language: en

Keywords

adult; human; female; case report; suicide attempt; drug overdose; article; antidepressant agent; mirtazapine; venlafaxine; automutilation; priority journal; cognitive therapy; impulsiveness; coping behavior; paracetamol; social behavior; borderline state; weight gain; valproic acid; escitalopram; ibuprofen; body weight disorder; mental instability; deterioration; drug dose reduction; therapeutic community; drug dose increase; hospital readmission; zuclopenthixol decanoate; emotional abuse